EurekAlert! -
29 Apr 2021 06:00
(Geisinger Health System) The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer.
Share this Article